Friday | 21 November, 2008
Stories about: SkyePharma
- +
Phosphagenics appoints pharma veteran 08/07/2008 16:30:45
Michael Ashton joins Phosphagenics' board - +
SkyePharma jumps as lung drug deal nears 29/04/2005 14:45:16
Britain's SkyePharma is close to a deal on one of its lung drugs that could be worth US$160 million, the drug delivery firm has claimed, boosting its shares as it posted a narrower loss for 2004. - +
CRO Novotech springboards into US 15/06/2004 15:36:59
Australian CRO Novotech is setting up operations in the US to take advantage of the clinical trials opportunities offered there. - +
Meditech teams up to market skin cancer treatment 10/09/2002 15:17:19
Meditech Research and SkyePharma have completed a commercial pas-de-deux that sees them divide up the Pacific Rim markets for the Solarase, a topical treatment for the pre-cancerous skin condition, actinic or solar keratosis.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Kingston Technology Launches HyperX T1 Series Memory 2008-11-19 11:00:00+11
Erase your discs with Lite-On SmartErase 2008-11-12 14:00:00+11
Antarctica NZ to Optimise Satellite Communications over the WAN with Expand Networks 2008-11-11 08:22:00+11
Kingston Technology Launches HyperX DDR3 2GHz Triple-Channel Memory in Support of Intel Core i7, X58 Platforms 2008-11-06 16:40:00+11
WD TV™ HD Media Player brings Digital Media Collections to the Big Screen 2008-11-05 11:00:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
